Overview
Acute upper gastrointestinal hemorrhage (AUGIB) is a critical medical emergency characterized by significant bleeding from the upper gastrointestinal tract, typically involving the esophagus, stomach, or duodenum. This condition is clinically significant due to its potential for rapid deterioration, high mortality rates ranging from 3% to 14%, and substantial morbidity. AUGIB predominantly affects older adults, with risk factors including Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose aspirin, anticoagulants like warfarin, and selective serotonin reuptake inhibitors (SSRIs). In day-to-day practice, prompt recognition and management are crucial to mitigate complications and improve patient outcomes. 135Pathophysiology
Acute upper gastrointestinal hemorrhage arises primarily from mucosal damage leading to erosions or ulcers in the upper gastrointestinal tract. Peptic ulcers, often exacerbated by factors such as H. pylori infection and NSAID use, are a leading cause. The pathophysiology involves disruption of the mucosal barrier, which exposes underlying blood vessels to gastric acid and proteolytic enzymes, initiating bleeding. Hemodynamic instability can rapidly ensue, driven by hypovolemia and shock. The presence of high-risk stigmata identified during endoscopy, such as active bleeding, visible vessel, or adherent clot, further escalates the risk of rebleeding and mortality. 46Epidemiology
The incidence of acute upper gastrointestinal bleeding ranges from 36 to 172 per 100,000 inhabitants annually, with recent studies indicating a declining trend in Western countries, attributed partly to reduced H. pylori prevalence and improved management of NSAID use. The condition predominantly affects older adults, with a median age often above 60 years. Geographic variations exist, though specific regional differences are not extensively detailed in the provided sources. Risk factors include chronic NSAID use, low-dose aspirin therapy, warfarin, and SSRIs, with varying degrees of evidence linking these to increased bleeding risk. 35Clinical Presentation
Patients with acute upper gastrointestinal hemorrhage typically present with hematemesis (vomiting of blood), melena (black, tarry stools), or hematochezia (bright red blood per rectum). Additional symptoms may include epigastric pain, dizziness, syncope, and signs of hypovolemic shock such as tachycardia and hypotension. Red-flag features include persistent hypotension, ongoing bleeding, and signs of significant coagulopathy, necessitating urgent intervention. Early recognition of these symptoms is critical for timely management and improved outcomes. 35Diagnosis
The diagnostic approach for acute upper gastrointestinal hemorrhage involves a combination of clinical assessment and diagnostic procedures. Key steps include:Clinical Evaluation: Assess vital signs, history of bleeding symptoms, medication use (especially NSAIDs, anticoagulants), and comorbidities.
Laboratory Tests: Complete blood count (CBC) to evaluate hemoglobin levels and platelet count; coagulation profile including INR and PT/PTT.
Endoscopy: Recommended within 24 hours of presentation to identify the source of bleeding, assess stigmata of recent hemorrhage, and perform therapeutic interventions if necessary.Specific Criteria and Tests:
Hemoglobin Levels: < 7 g/dL often indicates significant blood loss.
Coagulation Parameters: INR > 3.0 or PT > 20 seconds suggests coagulopathy.
Endoscopic Findings: High-risk stigmata include active bleeding, visible vessel, and adherent clot.Differential Diagnosis:
Peptic Ulcer Disease: Distinguished by endoscopic findings and history of NSAID use.
Esophageal Varices: Typically associated with liver disease and characteristic endoscopic appearance.
Mallory-Weiss Tears: Often presents with hematemesis and history of forceful vomiting or retching.
Aortic Dissection: Presents with sudden, severe chest or upper abdominal pain; ruled out by imaging studies. 345Management
Initial Management
Stabilization: Rapid assessment and resuscitation with intravenous fluids to maintain hemodynamic stability. Blood transfusion as needed to maintain hemoglobin levels above 7 g/dL.
Gastric Acid Suppression: Administration of high-dose proton pump inhibitors (PPIs) to reduce gastric acid secretion and promote hemostasis.Specific Steps:
Fluid Resuscitation: Crystalloids or colloids as needed.
Blood Transfusion: Packed red blood cells to correct anemia and stabilize hemodynamics.
PPI Administration: High-dose PPI (e.g., intravenous pantoprazole 80 mg bolus followed by continuous infusion).Endoscopic Intervention
Endoscopic Therapy: Performed within 24 hours to identify and treat the source of bleeding. Techniques include endoscopic band ligation, sclerotherapy, and thermal coagulation.Specific Techniques:
Band Ligation: For esophageal varices.
Thermal Coagulation: For peptic ulcers with high-risk stigmata.
Sclerotherapy: For esophageal varices or other bleeding lesions.Medical Management
Control Rebleeding: Continued PPI therapy post-endoscopy to prevent rebleeding.
Anticoagulant Management: Hold anticoagulants if indicated; reverse anticoagulation if necessary (e.g., vitamin K, prothrombin complex concentrate).Specific Medications:
PPIs: Continued infusion post-endoscopy.
Anticoagulant Reversal: Vitamin K, prothrombin complex concentrate (PCC), or fresh frozen plasma (FFP) as needed.Surgical Intervention
Indicated for: Persistent bleeding despite endoscopic therapy, hemodynamic instability, or complications like perforation.
Procedures: May include surgical hemostasis, resection of bleeding lesions, or emergency surgery for complications.Specific Scenarios:
Persistent Bleeding: Surgical intervention if endoscopic measures fail.
Perforation: Immediate surgical repair.Contraindications
Refractory Bleeding: When endoscopic and medical interventions fail.
Severe Coagulopathy: Uncorrectable coagulopathy precluding endoscopic procedures.Complications
Common complications of acute upper gastrointestinal hemorrhage include:
Rebleeding: Risk increases with high-risk stigmata identified endoscopically.
Hypovolemic Shock: Persistent hypotension and organ dysfunction.
Acute Kidney Injury: Due to hypovolemia and nephrotoxic effects of resuscitation fluids.
Pulmonary Complications: Aspiration pneumonia, atelectasis.
Infection: Postoperative or nosocomial infections.Management Triggers:
Rebleeding: Immediate re-endoscopy and surgical consultation.
Shock: Intensified resuscitation, potential ICU admission.
Acute Kidney Injury: Monitoring renal function, fluid management adjustments.Prognosis & Follow-up
The prognosis for patients with acute upper gastrointestinal hemorrhage varies based on severity and response to initial management. Key prognostic indicators include initial hemodynamic stability, source control success, and absence of rebleeding. Follow-up typically involves:
Short-term: Regular monitoring of vital signs, hemoglobin levels, and coagulation status.
Long-term: Evaluation of underlying causes (e.g., peptic ulcer disease, liver disease) and risk factor modification (e.g., discontinuation of NSAIDs, management of anticoagulation).Recommended Intervals:
Initial: Daily monitoring in ICU or high dependency unit.
Subsequent: Weekly outpatient visits for 1-2 months, then monthly as clinically indicated.Special Populations
Elderly Patients
Considerations: Increased frailty, comorbidities, and potential for polypharmacy contributing to bleeding risk.
Management: Careful fluid and blood product management, close monitoring of vital signs.Patients on Anticoagulants
Management: Rapid assessment and reversal strategies as needed, close collaboration with hematology.Pregnancy
Considerations: Unique challenges in imaging and endoscopic procedures; consult maternal-fetal medicine specialists.
Management: Minimize radiation exposure, prioritize non-invasive diagnostic methods where possible.Key Recommendations
Prompt Endoscopic Evaluation: Perform endoscopy within 24 hours of presentation to identify and treat the source of bleeding (Evidence: Strong 34).
High-Dose PPI Administration: Initiate high-dose intravenous PPIs early to reduce gastric acid secretion and promote hemostasis (Evidence: Strong 4).
Resuscitation with Fluids and Blood Products: Stabilize hemodynamics with appropriate fluid resuscitation and blood transfusions as needed (Evidence: Strong 3).
Hold or Reverse Anticoagulants: Temporarily discontinue anticoagulants and consider reversal strategies if indicated (Evidence: Moderate 5).
Endoscopic Therapy for High-Risk Lesions: Perform endoscopic interventions for lesions with high-risk stigmata to reduce rebleeding risk (Evidence: Strong 4).
Surgical Consultation for Refractory Cases: Involve surgical teams early for persistent bleeding or complications (Evidence: Moderate 5).
Close Monitoring of Coagulation: Regularly assess coagulation parameters and manage accordingly (Evidence: Moderate 3).
Risk Factor Modification: Address and modify underlying risk factors post-discharge to prevent recurrence (Evidence: Expert opinion 5).
Intensive Care Unit Admission for Hemodynamic Instability: Transfer patients with hemodynamic instability to ICU for close monitoring (Evidence: Moderate 3).
Long-Term Follow-Up: Schedule regular follow-up visits to monitor recovery and manage underlying conditions (Evidence: Expert opinion 5).References
1 Quaile O, Perrodin SF, Trippel A, Schnüriger B. Characteristics of emergency general surgery services in Switzerland: a nationwide survey. European journal of trauma and emergency surgery : official publication of the European Trauma Society 2024. link
2 Skelhorne-Gross G, Nenshi R, Jerath A, Gomez D. Structures, processes and models of care for emergency general surgery in Ontario: a cross-sectional survey. CMAJ open 2021. link
3 Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scandinavian journal of gastroenterology 2013. link
4 Holster IL, Kuipers EJ. Management of acute nonvariceal upper gastrointestinal bleeding: current policies and future perspectives. World journal of gastroenterology 2012. link
5 Kate V, Sureshkumar S, Gurushankari B, Kalayarasan R. Acute Upper Non-variceal and Lower Gastrointestinal Bleeding. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2022. link
6 Ogola GO, Gale SC, Haider A, Shafi S. The financial burden of emergency general surgery: National estimates 2010 to 2060. The journal of trauma and acute care surgery 2015. link